IGMS Crosses Above Average Analyst Target
January 23, 2020 at 08:20 AM EST
In recent trading, shares of IGM Biosciences Inc (IGMS) have crossed above the average analyst 12-month target price of $39.25, changing hands for $39.37/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..